Cure51
cure51.com
As featured in
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Financials
Overview
Cure51 collects and analyses the biological data of exceptional cancer survivors to find what made their outcome possible. Its platform combines a global clinical network with multi-omics data science. The company is headquartered in Paris.
News
Cure51 Launches NHS-Approved Study With Cambridge University Hospitals and Seven Other Leading UK Oncology Institutions to Unlock Cancer Survival Secrets
Read more
Report
Cure51 raises a €15M seed round aiming to crack the code on cancer survival
Rather than grimly assembling data about cancer deaths to predict outcomes in treatment, the founders of Cure51 had another idea: Instead, the company assembles data about long-term survivors of cancer, hoping to crack the code on what keeps people alive.
Read more
Report
Cure51: €15 Million Secured To Advance Biological Mechanisms For Survivors Among Cancer Patients
Cure51 - a biotech company looking to unlock the biological mechanisms responsible for exceptional survivors among cancer patients - announced it has successfully raised €15 million in a seed funding round led by Sofinnova Partners. Other investors in thi
Read more
Report
Cure51 raises a €15 million seed round to harness the natural power of cancer survivors to develop first-in-class treatments and transform cancer into a curable disease
/PRNewswire/ -- Cure51, a techbio company seeking to unlock the biological mechanisms responsible for exceptional survivors among cancer patients, today...
Read more
Report
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Paris
France
HQ